CSL works with rivals on COVID-19 treatment from recovered patients’ blood

Australian listed biotechnology giant CSL will work with some of its biggest rivals in the blood plasma business to try to develop a potential treatment for patients suffering complications from COVID-19. CSL – which briefly took over from Commonwealth Bank as the ASX’s largest company by market value earlier this year – said on Monday […]